Design, synthesis and HIV-RT inhibitory activity of novel thiazolidin-4-one derivatives

Abstract

A series of 2-aryl-3-(4,5,6-trimethylpyrimidin-2-yl) thiazolidin-4-ones (1a–1c) and their derivatives bearing a lipophilic substituent, like acetoxy group (3a–3c), propionyloxy group (4a–4c), methyl (5d and 5e) at C-5 on thiazolidin-4-one ring were designed, synthesized and evaluated for their HIV-RT inhibitory activity. Using self-catalyzed Pummerer reaction, compounds 3a–3c and 4a–4c were obtained in good yield (63.1%–75.2%). Preliminary anti-HIV-RT test of these derivatives indicated that compounds 1a–1c, 4b (propionyloxy group at C-5) showed moderate HIV-RT inhibitory activity and compounds 5d and 5e with methyl at C-5 showed a weak HIV-RT inhibitory activity. Structure activity relationship analysis suggested that the substituted groups on C-5 would be unfavorable to anti-HIV-RT activity and that the steric effect might play a critical role in the anti-HIV RT activity.

Keywords

5-subsituted thiazolidin-4-ones / Pummerer reaction / anti-HIV-RT activity / SARs

References

[1] Verma A, Saraf S K. 4-thiazolidinone—a biologically active scaffold. European Journal of Medicinal Chemistry, 2008, 43(5): 897–905

[2] Ramachandran R, Rani M, Kabilan S. Design, synthesis and biological evaluation of novel 2-[(2,4-diaryl-3-azabicyclo[3.3.1]nonan-9-ylidene)hydrazono]-1,3-thiazolidin-4-ones as a new class of antimicrobial agents. Bioorganic & Medicinal Chemistry Letters, 2009, 19(10): 2819–2823

[3] Kamel M M, Ali H I, Anwar M M, Mohamed N A, Soliman A M. Synthesis, antitumor activity and molecular docking study of novel sulfonamide-Schiff’s bases, thiazolidinones, benzothiazinones and their C-nucleoside derivatives. European Journal of Medicinal Chemistry, 2010, 45(2): 572–580

[4] Patel N B, Shaikh F M. Synthesis and antimicrobial activity of new 4-thiazolidinone derivatives containing 2-amino-6-methoxybenzothiazole. Saudi Pharmaceutical Journal, 2010, 18: 129–136

[5] Amin K M, Kamel M M, Anwar M M, Khedr M, Syam Y M. Synthesis, biological evaluation and molecular docking of novel series of spiro [(2H,3H) quinazoline-2,1′- cyclohexan]-4(1H)- one derivatives as anti-inflammatory and analgesic agents. European Journal of Medicinal Chemistry, 2010, 45(6): 2117–2131

[6] Ronad P M, Noolvi M N, Sapkal S, Dharbhamulla S, Maddi V S. Synthesis and antimicrobial activity of 7-(2-substituted phenylthiazolidinyl)-benzopyran-2-one derivatives. European Journal of Medicinal Chemistry, 2010, 45(1): 85–89

[7] Zhang X Y, Li X Y, Li D F, Qu G R, Wang J J, Loiseau P M, Fan X S. Ionic liquid mediated and promoted eco-friendly preparation of thiazolidinone and pyrimidine nucleoside-thiazolidinone hybrids and their antiparasitic activities. Bioorganic & Medicinal Chemistry Letters, 2009, 19(22): 6280–6283

[8] Abd Alla M S, Hegab M I, Abo Taleb N A, Hasabelnaby S M, Goudah A. Synthesis and anti-inflammatory evaluation of some condensed [4-(3,4-dimethylphenyl)-1(2H)-oxo-phthalazin-2-yl]acetic acid hydrazide. European Journal of Medicinal Chemistry, 2010, 45(4): 1267–1277

[9] Pan B, Huang R Z, Han S Q, Qu D, Zhu M L, Wei P, Ying H J. Design, synthesis, and antibiofilm activity of 2-arylimino-3-aryl-thiazolidine-4-ones. Bioorganic & Medicinal Chemistry Letters, 2010, 20(8): 2461–2464

[10] Rao A, Balzarini J, Carbone A, Chimirri A, De Clercq E, Monforte A M, Monforte P, Pannecouque C, Zappalà M. 2-(2,6-Dihalophenyl) -3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors. Antiviral Research, 2004, 63(2): 79–84

[11] Rao A, Balzarini J, Carbone A, Chimirri A, De Clercq E, Monforte A M, Monforte P, Pannecouque C, Zappalà M. Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents. II Farmaco, 2004, 59(1): 33–39

[12] Barreca M L, Chimirri A, De Clercq E, De Luca L, Monforte A M, Monforte P, Rao A, Zappalà M. Anti-HIV agents: design and discovery of new potent RT inhibitors. Il Farmaco, 2003, 58(3): 259–263

[13] Rao A, Carbone A, Chimirri A, De Clercq E, Monforte A M, Monforte P, Pannecouque C, Zappalà M. Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones. II Farmaco, 2003, 58(2): 115–120

[14] Barreca M L, Balzarini J, Chimirri A, De Clercq E, De Luca L, Höltje H D, Höltje M, Monforte A M, Monforte P, Pannecouque C, Rao A, Zappalà M. Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents. Journal of Medicinal Chemistry, 2002, 45(24): 5410–5413

[15] Rao A, Carbone A, Chimirri A, De Clercq E, Monforte A M, Monforte P, Pannecouque C, Zappalà M. Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-(thi)one derivatives. Il Farmaco, 2002, 57(9): 747–751

[16] Barreca M L, Chimirri A, De Luca L, Monforte A M, Monforte P, Rao A, Zappalà M, Balzarini J, De Clercq E, Pannecouque C, Witvrouw M. Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents. Bioorganic & Medicinal Chemistry Letters, 2001, 11(13): 1793–1796

[17] Rawal R K, Tripathi R, Katti S B, Pannecouque C, De Clercq E. Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3- thiazolidin-4-ones as anti-HIV agents. Bioorganic & Medicinal Chemistry, 2007, 15(4): 1725–1731

[18] Rawal R K, Tripathi R, Katti S B, Pannecouque C, De Clercq E. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents. European Journal of Medicinal Chemistry, 2008, 43(12): 2800–2806

[19] Rawal R K, Tripathi R, Katti S B, Pannecouque C, De Clercq E. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents. Bioorganic & Medicinal Chemistry, 2007, 15(9): 3134–3142

[20] Rawal R K, Prabhakar Y S, Katti S B, De Clercq E. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors. Bioorganic & Medicinal Chemistry, 2005, 13(24): 6771–6776

[21] Rawal R K, Tripathi R K, Katti S B, Pannecouque C, De Clercq E. Synthesis and biological evaluation of 2,3-diaryl substituted-1,3-thiazolidin-4-ones as anti-HIV agents. Medicinal Chemistry (Shariqah, United Arab Emirates), 2007, 3(4): 355–363

[22] Rawal R K, Tripathi R, Kulkarni S, Paranjape R, Katti S B, Pannecouque C, De Clercq E. 2-(2,6-Dihalo-phenyl)-3-heteroaryl-2-ylmethyl-1, 3-thiazolidin-4-ones: anti-HIV agents. Chemical Biology & Drug Design, 2008, 72(2): 147–154

[23] Rawal R K, Solomon V R, Prabhakar Y S, Katti S B, De Clercq E. Synthesis and QSAR studies on thiazolidinones as anti-HIV agents. Combinatorial Chemistry & High Throughput Screening, 2005, 8(5): 439–443

[24] Prabhakar Y S, Solomon V R, Rawal R K, Gupta M K, Katti S B. CP-MLR/PLS directed structure-activity modeling of the HIV-1 RT inhibitory activity of 2,3-diaryl-1,3-thiazolidin-4-ones. QSAR & Combinatorial Science, 2004, 23(4): 234–244

[25] Prabhakar Y S, Rawal R K, Gupta M K, Solomon V R, Katti S B. Topological descriptors in modeling the HIV inhibitory activity of 2-aryl-3-pyridyl-thiazolidin-4-ones. Combinatorial Chemistry & High Throughput Screening, 2005, 8(5): 431–437

[26] Roy K, Leonard J T. Classical QSAR modeling of anti-HIV 2,3-diaryl-1,3- thiazolidin-4-ones. QSAR & Combinatorial Science, 2005, 24(5): 579–592

[27] Ravichandran V, Prashantha Kumar B R, Sankar S, Agrawal R K. Predicting anti-HIV activity of 1,3,4-thiazolidinone derivatives: 3D-QSAR approach. European Journal of Medicinal Chemistry, 2009, 44(3): 1180–1187

[28] Murugesan V, Prabhakar Y S, Katti S B. CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents. Journal of Molecular Graphics & Modelling, 2009, 27(6): 735–743

[29] Balzarini J, Orzeszko-Krzesińska B, Maurin J K, Orzeszko A. Synthesis and anti-HIV studies of 2- and 3-adamantyl-substituted thiazolidin-4-ones. European Journal of Medicinal Chemistry, 2009, 44(1): 303–311

[30] Balzarini J, Orzeszko B, Maurin J K, Orzeszko A. Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-ones. European Journal of Medicinal Chemistry, 2007, 42(7): 993–1003

[31] Chen H, Bai J, Jiao L L, Guo Z H, Yin Q M, Li X L. Design, microwave-assisted synthesis and HIV-RT inhibitory activity of 2-(2,6-dihalophenyl)-3-(4,6-dimethyl-5-(un)substituted-pyrimidin-2-yl)thiazolidin-4-ones. Bioorganic & Medicinal Chemistry, 2009, 17(11): 3980–3986

[32] Colombo A, Fernàndez J C, Fernández-Forner D, dela Figuera N, Albericio F, Forns P. Stereomeric studies on the oxidation and alkylation of 4-thiazolidinones. Tetrahedron Letters, 2008, 49(10): 1569–1572

[33] Colombo A, Albericio F, Forns P. Sulfoxidations in the solid phase. Tetrahedron, Asymmetry, 2006, 17(24): 3327–3331

[34] Arey B J, Yanofsky S D, Claudia Pérez M, Holmes C P, Wrobel J, Gopalsamy A, Stevis P E, López F J, Winneker R C. Differing pharmacological activities of thiazolidinone analogs at the FSH receptor. Biochemical and Biophysical Research Communications, 2008, 368(3): 723–728

[35] Wrobel J, Jetter J, Kao W, Rogers J, Di L, Chi J, Peréz M C, Chen G C, Shen E S. 5-Alkylated thiazolidinones as follicle-stimulating hormone (FSH) receptor agonists. Bioorganic & Medicinal Chemistry, 2006, 14(16): 5729–5741

[36] De Lucchi O, Miotti U, Midena G. The Pummerer reaction of sulfinyl compounds. Organic Reactions, 1991, 40: 158–188

[37] Kürti L, Czakó B. Strategic Applications of Named Reactions in Organic Synthesis. Beijing: Science Publication, 2007, 368

[38] Reverse Transcriptase Assay, Colorimetric kit, Roche Diagnostics GmbH. Roche Applied Science, Sandhofer Strasse 116, D-68305 Mannheim, Germany

[39] Rao A, Chimirri A, Ferro S, Monforte A M, Monforte P, Pannecouque C, Zappalà M. Microwave-induced synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors. ARKIVOC, 2004: 147–155

[40] Bolognese A, Correale G, Manfra M, Lavecchia A, Novellino E, Barone V. Thiazolidin-4-one formation. Mechanistic and synthetic aspects of the reaction of imines and mercaptoacetic acid under microwave and conventional heating. Organic & Biomolecular Chemistry, 2004, 2(19): 2809–2813

[41] Srivastava T, Haq W, Katti S B. Carbodiimide mediated synthesis of 4-thiazolidinones by one-pot three-component condensation. Tetrahedron, 2002, 58(38): 7619–7624

[42] Gududuru V, Nguyen V, Dalton J T, Miller D D. Efficient microwave enhanced synthesis of 4-thiazolidinones. Synlett, 2004, 13: 2357–2358

[43] Fraga-Dubreuil J, Bazureau J P. Efficient combination of task-specific ionic liquid and microwave dielectric heating applied to one-pot three component synthesis of a small library of 4-thiazolidinones. Tetrahedron, 2003, 59(32): 6121–6130

[44] Dandia A, Singh R, Khaturia S, Mérienne C, Morgant G, Loupy A. Efficient microwave enhanced regioselective synthesis of a series of benzimidazolyl/triazolyl spiro [indole-thiazolidinones] as potent antifungal agents and crystal structure of spiro[3H-indole-3,2'-thiazolidine]-3'(1,2,4-triazol-3-yl)-2,4'(1H)-dione. Bioorganic & Medicinal Chemistry, 2006, 14(7): 2409–2417

[45] Sriram D, Yogeeswari P, Kumar T G A. Microwave-assisted synthesis and anti-YFV activity of 2,3-diaryl-1,3-thiazolidin-4-ones. Journal of Pharmacy & Pharmaceutical Sciences, 2005, 8(3): 426–429

[46] Yadav A K, Kumar M, Yadav T, Jain R. An ionic liquid mediated one-pot synthesis of substituted thiazolidinones and benzimidazoles. Tetrahedron Letters, 2009, 50(35): 5031–5034

[47] Mali J R, Pratap U R, Netankar P D, Mane R A. An efficient synthetic route for quinazolinyl 4-thiazolidinones. Tetrahedron Letters, 2009, 50(35): 5025–5027

[48] Chen H, Bai J, Zhao L, Yuan X G, Li X L, Cao K Q. Microwave assisted synthesis and antibacterial study of 3-naphthyl-2-[(un)substituted phenyl]-1,3-thiazolidin-4-ones. Chin J Org Chem, 2008, 28: 1092–1096 (in Chinese)

[49] Chen H, Bai J, Zhao L, Yuan X G, Li X L, Cao K Q. Microwave assisted synthesis and antifungal, anti-tumor study of 2-(2,6-Dichlorophenyl)-1,3-thiazolidin-4-ones. Chin J Org Chem, 2009, 29: 94–99 (in Chinese)

[50] Mamaghani M, Loghmanifar A, Taati M R. An efficient one-pot synthesis of new 2-imino-1,3-thiazolidin-4-ones under ultrasonic conditions. Ultrasonics Sonochemistry, 2011, 18(1): 45–48

[51] Neuenfeldt P D, Drawanz B B, Siqueira G M, Gomes C R B, Wardell S M S V, Flores A F C, Cunico W. Efficient solvent-free synthesis of thiazolidin-4-ones from phenylhydrazine and 2,4-dinitrophenylhydrazine. Tetrahedron Letters, 2010, 51(23): 3106–3108

Acknowledgments

The financial support from the National Natural Science Foundation of China (Grant No. 20672027) and the Natural Science Foundation of Hebei Province (2008000588) are gratefully acknowledged.

RIGHTS & PERMISSIONS

2014 Higher Education Press and Springer-Verlag Berlin Heidelberg